About Ascendis Pharma

Ascendis Pharma A/S is an emerging pharmaceutical company which is creating improved, patentable versions of both currently marketed drugs and high-value development-stage opportunities. The company is built upon a novel transient linker technology, TransientLink, which conjugates peptides, proteins and small molecules to a carrier molecule in a reversible fashion. This unique reversibility allows an unmodified active drug to be released (unlinked) in the body in a precise, time-controlled fashion, creating a long-acting effect. Conventional conjugation technologies are unable to achieve this type of slow-release mechanism because the polymer cannot de-link from the drug.

Ascendis` commercial headquarters is based in Copenhagen, Denmark. Our research organization, formerly known as Complex Biosystems, is located in Heidelberg Germany, and our clinical & regulatory organization is located in New Jersey, US.

The expertise at the three sites creates a continuum from discovery to clinical development and commercialization that will facilitate rapid product development.

• Management
• Board of Directors